Ownership history in NATIXIS · 11 quarters on record
This page tracks every 13F SEC filing in which NATIXIS reported a position in NEOGENOMICS INC (NEO). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q3 | UNCHANGED | 150 | — | 0% | 0.00% | $1K | $7.72 |
| 2025 Q2 | UNCHANGED | 150 | — | 0% | 0.00% | $1K | $7.31 |
| 2025 Q1 | UNCHANGED | 150 | — | 0% | 0.00% | $1K | $9.49 |
| 2024 Q4 | UNCHANGED | 150 | — | 0% | 0.00% | $2K | $16.48 |
As of 2025 Q4 — sorted by position size